| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |